Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
Rutgers Cancer Institute’s Dr. Mark Stein and colleagues examined an oral drug that targets cancer cells and spares healthy tissue in a ‘first in human’ clinical trial that defined a safe dosage and found the investigational drug to be well tolerated.
Dr. Steven K. Libutti recently began his role as the new Director of Rutgers Cancer Institute and Vice Chancellor for Cancer Programs, RBHS. Through enhanced collaboration with RWJBarnabas Health, Rutgers Cancer Institute continues to enrich its role as the State’s only NCI-designated Comprehensive Cancer Center. Read more
Cancer research is one of the pillars of the Cancer Institute of New Jersey. Our physician-scientists engage in innovative techniques to unlock the mysteries of cancer, helping to make unique advances in the field.